The entry of tumor cells into the bone microenvironment may cause a number of significant changes including an increase in growth factors (eg, parathyroid hormone–related protein), which causes an upregulation of RANKL, and downregulation of osteoprotegerin (OPG),123 which enhances osteoclast function resulting in greater bone degradation. Here, TNFRSF11B is linked to neoplasm.